Chidamide combined with paclitaxel effectively reverses the expression of histone deacetylase in lung cancer

The role of histone deacetylases (HDACs) in lung cancer has been extensively studied. Inhibition of HDAC activities have been used as a new cancer treatment strategy. To date, many HDAC inhibitors have been shown to induce apoptosis and inhibit tumorigenesis. Chidamide (CS055) is a new member of HDA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Na, Sun, Pan, Jin, Haizhen, Yang, Yuqin, Zhao, Qingya, Zhou, Lin, Guo, Lili, Yang, Xiaohua, Lu, Liming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Preclinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365669/
https://www.ncbi.nlm.nih.gov/pubmed/32701251
http://dx.doi.org/10.1097/CAD.0000000000000935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365669/
https://www.ncbi.nlm.nih.gov/pubmed/32701251
http://dx.doi.org/10.1097/CAD.0000000000000935

Ejemplares similares